Literature DB >> 24025979

Nocturnal and daytime esophageal acid exposure in normal-weight, overweight, and obese patients with reflux symptoms.

Jan S Burgerhart1, Paul C van de Meeberg, Peter D Siersema, André J P M Smout.   

Abstract

OBJECTIVES: This study aimed to investigate the association between BMI and esophageal acid exposure in a cohort of patients referred for esophageal pH monitoring. The contributing roles of hiatal hernia, lower esophageal sphincter (LES) pressure, and intragastric pressure (IGP) were investigated, with an emphasis on reflux in the supine position.
METHODS: Esophageal manometry and 24-h pH-metry results were extracted from a prospectively collected database, and supplemental data (body mass, endoscopy results) from patient files.
RESULTS: In total, 245 patients (mean age 52.2±14 years, 54% men) were included in this study. In the normal-weight subgroup (n=87), the median acid exposure time was 1.1% [0-8.1] in the supine position (with interquartile range 25-75%) and 7.7% [2.5-14.8] in the upright position; the total acid exposure time was 7.4% [2.7-11.7]/24 h. In the overweight subgroup (n=104), the median acid exposure time was 4.9% [0.3-13.3] in the supine position and 11.1% [5.4-16.9] in the upright position; the total acid exposure time was 8.9% [4.7-15.8]/24 h. In the obesity subgroup (n=54), the median acid exposure time was 4.1% [0.7-14.3] in the supine position and 10.5% [5-17.5] in the upright position; the total acid exposure time was 8.3% [5.3-14.7]/24 h. Supine acid exposure was significantly higher in overweight and obese patients than in normal-weight patients (both P=0.02). In overweight patients, a hiatal hernia was predictive of supine and total acid exposure, as was a decreasing LES pressure in both the supine and the upright position. In obese patients, increased IGP contributed toward an increased total acid exposure. Although an association between increasing BMI and acid exposure was observed, BMI was not independently predictive.
CONCLUSION: Overweight and obesity is associated with increased reflux, especially in the supine position. The most important factors that contribute toward reflux are the presence of a hiatal hernia and a lower LES pressure in overweight patients and an increased IGP in obese patients.

Entities:  

Mesh:

Year:  2014        PMID: 24025979     DOI: 10.1097/MEG.0b013e328365c3cb

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  6 in total

Review 1.  Lifestyle measures in the management of gastro-oesophageal reflux disease: clinical and pathophysiological considerations.

Authors:  J H-E Kang; J Y Kang
Journal:  Ther Adv Chronic Dis       Date:  2015-03       Impact factor: 5.091

2.  Higher Esophageal Symptom Burden in Obese Subjects Results From Increased Esophageal Acid Exposure and Not From Dysmotility.

Authors:  Benjamin D Rogers; Amit Patel; Dan Wang; Gregory S Sayuk; C Prakash Gyawali
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-20       Impact factor: 11.382

3.  Staple Line Intrathoracic Migration After Sleeve Gastrectomy: Correlation between Symptoms, CT Three-Dimensional Stomach Analysis, and 24-h pH Monitoring.

Authors:  Pascale Karila-Cohen; Anne-Laure Pelletier; Loukbi Saker; Cédric Laouénan; Delphine Bachelet; Antoine Khalil; Konstantinos Arapis
Journal:  Obes Surg       Date:  2022-05-02       Impact factor: 3.479

4.  The effect of concurrent esophageal pathology on bariatric surgical planning.

Authors:  Daniel Davila Bradley; Brian E Louie; Judy Chen; Ralph W Aye; Ross McMahon; Alexander S Farivar
Journal:  J Gastrointest Surg       Date:  2014-09-12       Impact factor: 3.452

5.  Can Omentopexy Reduce the Incidence of Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy.

Authors:  Saeid Shams Nosrati; Abdolreza Pazouki; Mohammad Sabzikarian; Mohammadali Pakaneh; Ali Kabir; Mohammad Kermansaravi
Journal:  Obes Surg       Date:  2020-08-18       Impact factor: 4.129

Review 6.  Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art.

Authors:  Vincenzo Savarino; Elisa Marabotto; Patrizia Zentilin; Maria Giulia Demarzo; Nicola de Bortoli; Edoardo Savarino
Journal:  Drug Des Devel Ther       Date:  2021-04-19       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.